» Articles » PMID: 33712918

Multiplex Detection of Blood-borne Pathogens on a Self-driven Microfluidic Chip Using Loop-mediated Isothermal Amplification

Overview
Specialty Chemistry
Date 2021 Mar 13
PMID 33712918
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Detection of blood-borne pathogens such as hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is essential to ensure the safety of blood transfusion. However, traditional PCR-based pathogen nucleic acid detection methods require relatively high experimental facilities and are difficult to apply in areas with limited resources. In this study, a self-driven microfluidic chip was designed to carry out multiplex detection of HBV, HCV and HIV by using loop-mediated isothermal amplification (LAMP). Benefitting from the air permeability of the polydimethylsiloxane material, the chip could accomplish sample loading within 12 min driven by the pressure difference between the reaction chambers and vacuum chambers in the chip without using pumps or any injection devices. Multiplex detection is achieved by presetting LAMP primers specific to different targets in different reaction chambers. Calcein was used as an indicator to indicate the positive amplification reaction, and the result can be recorded by a smartphone camera. After 50 min of isothermal amplification at 63 °C, 2 copies/μL of HBV, HCV and HIV target nucleic acids could be detected. The results of HBV detection of 20 clinical plasma samples by using the chip are consistent with that of the qPCR-based kit, indicating that the LAMP-based self-driven chip has the clinical application potential for blood-borne pathogen detection, especially in resource-limited areas.

Citing Articles

A paradigm shift in the detection of bloodborne pathogens: conventional approaches to recent detection techniques.

Khanal S, Pillai M, Biswas D, Islam M, Verma R, Kuca K EXCLI J. 2024; 23:1245-1275.

PMID: 39574968 PMC: 11579516. DOI: 10.17179/excli2024-7392.


Enhanced Point-of-Care SARS-CoV-2 Detection: Integrating RT-LAMP with Microscanning.

Choi M, Lee E, Park S, Lim C, Jang W Biosensors (Basel). 2024; 14(7).

PMID: 39056624 PMC: 11274610. DOI: 10.3390/bios14070348.


Point-of-Care Testing for Hepatitis Viruses: A Growing Need.

Pauly M, Ganova-Raeva L Life (Basel). 2023; 13(12).

PMID: 38137872 PMC: 10744957. DOI: 10.3390/life13122271.


LAMP-Based Point-of-Care Biosensors for Rapid Pathogen Detection.

Das D, Lin C, Chuang H Biosensors (Basel). 2022; 12(12).

PMID: 36551035 PMC: 9775414. DOI: 10.3390/bios12121068.


A microfluidic fully paper-based analytical device integrated with loop-mediated isothermal amplification and nano-biosensors for rapid, sensitive, and specific quantitative detection of infectious diseases.

Tavakoli H, Hirth E, Luo M, Timilsina S, Dou M, Dominguez D Lab Chip. 2022; 22(23):4693-4704.

PMID: 36349548 PMC: 9701502. DOI: 10.1039/d2lc00834c.


References
1.
Hoofnagle J, Seeff L, Bales Z, ZIMMERMAN H . Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med. 1978; 298(25):1379-83. DOI: 10.1056/NEJM197806222982502. View

2.
Kleinman S, Lelie N, Busch M . Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009; 49(11):2454-89. DOI: 10.1111/j.1537-2995.2009.02322.x. View

3.
Ramsey S, Unger J, Baker L, Little R, Loomba R, Hwang J . Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. JAMA Oncol. 2019; 5(4):497-505. PMC: 6459217. DOI: 10.1001/jamaoncol.2018.6437. View

4.
Stramer S, Glynn S, Kleinman S, Strong D, Caglioti S, Wright D . Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004; 351(8):760-8. DOI: 10.1056/NEJMoa040085. View

5.
Zou S, Dorsey K, Notari E, Foster G, Krysztof D, Musavi F . Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 2010; 50(7):1495-504. DOI: 10.1111/j.1537-2995.2010.02622.x. View